A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
H. Lee Moffitt Cancer Center and Research Institute
Neonc Technologies, Inc.
M.D. Anderson Cancer Center
Vyriad, Inc.
TCR2 Therapeutics
Incyte Corporation
Vanderbilt-Ingram Cancer Center
Bristol-Myers Squibb
Gritstone bio, Inc.
Gritstone bio, Inc.
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Incyte Corporation
Incyte Corporation
NYU Langone Health